Fucokinase plays a crucial role in the metabolism of fucose, a deoxyhexose sugar pivotal to several biological processes such as cellular communication, immune response, and the modification of glycoproteins and glycolipids. Through catalyzing the conversion of L-fucose to L-fucose-1-phosphate, fucokinase facilitates the incorporation of fucose into cellular mechanisms, highlighting its significance in the salvage pathway of fucose metabolism. This enzyme ensures the effective utilization of fucose from the breakdown of glycoconjugates, thereby maintaining the balance of fucose-containing compounds essential for proper cell function. The activity of fucokinase directly impacts the synthesis and remodeling of glycoconjugates, implicating its importance in processes ranging from cell adhesion to the immune response.
The inhibition of fucokinase, consequently, disrupts the fucose salvage pathway, leading to a decrease in the available pool of fucose-1-phosphate for the synthesis of GDP-fucose, the active donor molecule for fucosylation reactions. Inhibition can occur through various mechanisms, including the competitive binding of molecules that resemble the enzyme's natural substrate or allosteric modulation where the inhibitor binds to a site other than the active site, causing a conformational change that reduces enzyme activity. Additionally, downregulation of fucokinase gene expression or post-translational modifications that alter the enzyme's activity can serve as mechanisms of inhibition. These inhibitory processes can lead to a reduced capacity for the cell to fucosylate glycoconjugates, affecting cellular recognition and signaling pathways. Understanding the precise mechanisms through which fucokinase is inhibited can provide insight into the regulation of fucosylation processes within the cell and the broader implications of disrupted fucose metabolism in cellular function and disease states. The study of fucokinase inhibition, therefore, not only elucidates the enzyme's role in cellular metabolism but also underscores the complex regulatory networks that govern cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
Analog of glucose that interferes with glycolysis and can indirectly influence pathways connected to Fucokinase. | ||||||
Manoalide | 75088-80-1 | sc-200733 | 1 mg | $264.00 | 9 | |
Known to inhibit various enzymes involved in glycosylation, which can influence fucose metabolism and potentially the activity of Fucokinase. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
Inhibits Class III PI3K which can impact autophagy, affecting cellular metabolism, and indirectly influencing Fucokinase's pathway. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $72.00 $142.00 | ||
Glucosidase inhibitor that can impede glycoprotein processing, potentially affecting GDP-fucose synthesis. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
Mannosidase inhibitor which affects glycoprotein processing, indirectly affecting fucose metabolism. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
Mannosidase inhibitor that affects glycan processing, potentially affecting pathways related to Fucokinase. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
Glucosidase inhibitor that can influence glycoprotein processing, thereby potentially affecting GDP-fucose synthesis. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Antibiotic that affects ion transport and glycosylation, potentially impacting the function of Fucokinase indirectly. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $45.00 $110.00 $235.00 $6940.00 $26879.00 | 9 | |
Antibiotic affecting ion transport and glycosylation which can influence the metabolism pathways related to Fucokinase. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $61.00 | 8 | ||
Affects pH inside vesicles, influencing glycan processing which can indirectly impact pathways Fucokinase is involved in. |